1,258 results on '"P. Greenway"'
Search Results
2. Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.
- Author
-
de la Salle, Sara, Kettner, Hannes, Thibault Lévesque, Julien, Garel, Nicolas, Dames, Shannon, Patchett-Marble, Ryan, Rej, Soham, Gloeckler, Sara, Erritzoe, David, Carhart-Harris, Robin, and Greenway, Kyle
- Subjects
Distress ,Palliative care ,Psilocybin-assisted psychotherapy ,Psychedelics ,Adult ,Aged ,Female ,Humans ,Male ,Middle Aged ,Anxiety ,Canada ,Compassionate Use Trials ,Depression ,Hallucinogens ,Longitudinal Studies ,North American People ,Prospective Studies ,Psilocybin ,Psychotherapy ,Quality of Life - Abstract
Recent clinical trials have found that the serotonergic psychedelic psilocybin effectively alleviates anxiodepressive symptoms in patients with life-threatening illnesses when given in a supportive environment. These outcomes prompted Canada to establish legal pathways for therapeutic access to psilocybin, coupled with psychological support. Despite over one-hundred Canadians receiving compassionate access since 2020, there has been little examination of these real-world patients. We conducted a prospective longitudinal survey which focused on Canadians who were granted Section 56 exemptions for legal psilocybin-assisted psychotherapy. Surveys assessing various symptom dimensions were conducted at baseline, two weeks following the session (endpoint), and optionally one day post-session. Participant characteristics were examined using descriptive statistics, and paired sample t-tests were used to quantify changes from baseline to the two-week post-treatment endpoint. Eight participants with Section 56 exemptions (four females, Mage = 52.3 years), all with cancer diagnoses, fully completed baseline and endpoint surveys. Significant improvements in anxiety and depression symptoms, pain, fear of COVID-19, quality of life, and spiritual well-being were observed. Attitudes towards death, medical assistance in dying, and desire for hastened death remained unchanged. While most participants found the psilocybin sessions highly meaningful, if challenging, one reported a substantial decrease in well-being due to the experience. These preliminary data are amongst the first to suggest that psilocybin-assisted psychotherapy can produce psychiatric benefits in real-world patients akin to those observed in clinical trials. Limited enrollment and individual reports of negative experiences indicate the need for formal real-world evaluation programs to surveil the ongoing expansion of legal access to psychedelics.
- Published
- 2024
3. Evolutionary Rate Shifts in Coding and Regulatory Regions Underpin Repeated Adaptation to Sulfidic Streams in Poeciliid Fishes.
- Author
-
De-Kayne, Rishi, Perry, Blair, McGowan, Kerry, Landers, Jake, Arias-Rodriguez, Lenin, Greenway, Ryan, Rodríguez Peña, Carlos, Tobler, Michael, and Kelley, Joanna
- Subjects
Poeciliidae ,adaptation ,convergent evolution ,extremophile ,hydrogen sulfide ,Animals ,Evolution ,Molecular ,Hydrogen Sulfide ,Adaptation ,Physiological ,Regulatory Sequences ,Nucleic Acid ,Phylogeny ,Poecilia - Abstract
Adaptation to extreme environments often involves the evolution of dramatic physiological changes. To better understand how organisms evolve these complex phenotypic changes, the repeatability and predictability of evolution, and possible constraints on adapting to an extreme environment, it is important to understand how adaptive variation has evolved. Poeciliid fishes represent a particularly fruitful study system for investigations of adaptation to extreme environments due to their repeated colonization of toxic hydrogen sulfide-rich springs across multiple species within the clade. Previous investigations have highlighted changes in the physiology and gene expression in specific species that are thought to facilitate adaptation to hydrogen sulfide-rich springs. However, the presence of adaptive nucleotide variation in coding and regulatory regions and the degree to which convergent evolution has shaped the genomic regions underpinning sulfide tolerance across taxa are unknown. By sampling across seven independent lineages in which nonsulfidic lineages have colonized and adapted to sulfide springs, we reveal signatures of shared evolutionary rate shifts across the genome. We found evidence of genes, promoters, and putative enhancer regions associated with both increased and decreased convergent evolutionary rate shifts in hydrogen sulfide-adapted lineages. Our analysis highlights convergent evolutionary rate shifts in sulfidic lineages associated with the modulation of endogenous hydrogen sulfide production and hydrogen sulfide detoxification. We also found that regions with shifted evolutionary rates in sulfide spring fishes more often exhibited convergent shifts in either the coding region or the regulatory sequence of a given gene, rather than both.
- Published
- 2024
4. Psychedelics and the inner healer: Myth or mechanism?
- Author
-
Peill, Joseph, Marguilho, Miriam, Erritzoe, David, Barba, Tommaso, Greenway, Kyle, Rosas, Fernando, Timmermann, Christopher, and Carhart-Harris, Robin
- Subjects
Healing ,Telos ,automatic ,psychedelic ,Humans ,Hallucinogens ,Psilocybin ,Double-Blind Method ,Adult ,Male ,Female ,Middle Aged ,Depression ,Young Adult ,Dose-Response Relationship ,Drug - Abstract
BACKGROUND: Reference to an intrinsic healing mechanism or an inner healer is commonplace amongst psychedelic drug-using cultures. The inner healer refers to the belief that psychedelic compounds, plants or concoctions have an intrinsically regenerative action on the mind and brain, analogous to intrinsic healing mechanisms within the physical body, for example, after sickness or injury. AIMS: Here, we sought to test and critique this idea by devising a single subjective rating item pertaining to perceived inner healing effects. METHODS: The item was issued to 59 patients after a single high (25 mg, n = 30) or placebo (1 mg, n = 29) dose of psilocybin in a double-blind randomised controlled trial of psilocybin for depression. RESULTS: Inner healer scores were higher after the high versus placebo dose of psilocybin (t = 3.88, p
- Published
- 2024
5. Autonomic and Enteric Profiling May Help Predict Response to Diverse Obesity Therapies
- Author
-
Eiswerth, Michael, Mathur, Prateek, Rashed, Hani, Greenway, Frank, Ravussin, Eric, Johnson, William, Jirapinyo, Pichamol, Thompson, Christopher C., Kehdy, Farid, Sarker, Shabnam, Naing, Le Yu, Daniels, Michael W., and Abell, Thomas
- Published
- 2024
- Full Text
- View/download PDF
6. A Proposed Systematic Approach to Safe Inter Hospital Patient Transfer in Interventional Radiology: From Referral to Repatriation
- Author
-
Wells, David, Morgan, Robert, and Greenway, Michael
- Published
- 2024
- Full Text
- View/download PDF
7. Effects of plasticity and genetic divergence in phenotypic trait expression of sulfide spring fishes
- Author
-
Nobrega, Madison, Greenway, Ryan, Passow, Courtney N., Arias Rodriguez, Lenin, and Tobler, Michael
- Published
- 2024
- Full Text
- View/download PDF
8. Shared decision making for perioperative antibiotic use during Mohs micrographic surgery on the lower extremitiesCapsule Summary
- Author
-
Lisa Fronek, DO, Michael J. Davis, MD, Hubert T. Greenway, MD, and Benjamin Kelley, MD
- Subjects
antibiotic prophylaxis ,Mohs surgery ,postoperative skin infection ,shared decision making ,Dermatology ,RL1-803 - Abstract
Background: While there is a higher risk of surgical site infection (SSI) on the lower extremities following Mohs micrographic surgery (MMS), antibiotic prophylaxis (AP) is debated. Objective: To determine the role of shared decision making (SDM) in guiding AP usage during MMS on the lower extremities. Materials and methods: A prospective observational study was conducted whereby patients received a standardized SDM discussion or routine counseling. Patient satisfaction quantified by the shared decision-making questionnaire (SDMQ9) survey, rate of SSI, and rate of AP prescription were recorded. Results: In total, 51 patients were included. While there were less antibiotics prescribed in the treatment group (20% versus 50%, P = .025), this did not affect incidence of SSI (8% in treatment group versus 7.7% in control group, P = .668). Patient satisfaction was statistically greater in SDM group (4.73 versus 2.18 in control (P
- Published
- 2024
- Full Text
- View/download PDF
9. The Predictive Value of Virtue: Many Virtues Predict Lower Depression and Anxiety Symptom Scores among College Students…But Gratitude Dominates
- Author
-
Tyler S. Greenway, Mason S. Ming, Juliette L. Ratchford, Perry L. Glanzer, Kevin D. Dougherty, and Sarah A. Schnitker
- Abstract
Depression and anxiety symptoms have risen in the last decade, especially among college students. Virtues are potentially strong predictive factors of mental health symptoms, but a minimal amount of research has explored "which" virtues are the strongest predictors. We examined the relative predictive strength of gratitude, forgiveness, patience, intellectual humility, and self-control using dominance analyses. Results suggested that gratitude had the strongest predictive value for lower anxiety and depressive symptom scores compared to forgiveness, intellectual humility, patience, and self-control. An implication of these findings is that when considering intervention work with young emerging adults, researchers may do well to start with gratitude, then promote other virtues such as forgiveness and self-control.
- Published
- 2024
- Full Text
- View/download PDF
10. Correction to: What do nurses experience in communication when assisting in robotic surgery: an integrative literature review
- Author
-
Lee, Lian, Greenway, Kathleen, and Schutz, Sue
- Published
- 2024
- Full Text
- View/download PDF
11. What do nurses experience in communication when assisting in robotic surgery: an integrative literature review
- Author
-
Lee, Lian, Greenway, Kathleen, and Schutz, Sue
- Published
- 2024
- Full Text
- View/download PDF
12. Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders
- Author
-
La Torre, Joseph T., Mahammadli, Mehdi, Faber, Sonya C., Greenway, Kyle T., and Williams, Monnica T.
- Published
- 2024
- Full Text
- View/download PDF
13. Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
- Author
-
Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara Gloeckler, David Erritzoe, Robin Carhart-Harris, and Kyle T. Greenway
- Subjects
Psychedelics ,Psilocybin-assisted psychotherapy ,Distress ,Palliative care ,Medicine ,Science - Abstract
Abstract Recent clinical trials have found that the serotonergic psychedelic psilocybin effectively alleviates anxiodepressive symptoms in patients with life-threatening illnesses when given in a supportive environment. These outcomes prompted Canada to establish legal pathways for therapeutic access to psilocybin, coupled with psychological support. Despite over one-hundred Canadians receiving compassionate access since 2020, there has been little examination of these ‘real-world’ patients. We conducted a prospective longitudinal survey which focused on Canadians who were granted Section 56 exemptions for legal psilocybin-assisted psychotherapy. Surveys assessing various symptom dimensions were conducted at baseline, two weeks following the session (endpoint), and optionally one day post-session. Participant characteristics were examined using descriptive statistics, and paired sample t-tests were used to quantify changes from baseline to the two-week post-treatment endpoint. Eight participants with Section 56 exemptions (four females, Mage = 52.3 years), all with cancer diagnoses, fully completed baseline and endpoint surveys. Significant improvements in anxiety and depression symptoms, pain, fear of COVID-19, quality of life, and spiritual well-being were observed. Attitudes towards death, medical assistance in dying, and desire for hastened death remained unchanged. While most participants found the psilocybin sessions highly meaningful, if challenging, one reported a substantial decrease in well-being due to the experience. These preliminary data are amongst the first to suggest that psilocybin-assisted psychotherapy can produce psychiatric benefits in real-world patients akin to those observed in clinical trials. Limited enrollment and individual reports of negative experiences indicate the need for formal real-world evaluation programs to surveil the ongoing expansion of legal access to psychedelics.
- Published
- 2024
- Full Text
- View/download PDF
14. The response of ostracod faunal assemblages to hydrology, lake level, and carbon cycling in a Jamaican marl lake: a palaeolimnological investigation
- Author
-
H. Greenway, J. Holmes, and M. Burn
- Subjects
Geology ,QE1-996.5 - Abstract
Ostracod taxa from shallow freshwater lakes are sensitive to a range of limnological factors including temperature, hydrological habitat, lake level, and the distribution of aquatic plants. Ostracod assemblages preserved in Quaternary lake sediments can be used to reconstruct limnological change and are therefore potentially valuable palaeoenvironmental proxies. However, lack of autecological information about some taxa may limit the validity of such reconstructions. We use fossil ostracod assemblages recovered from radiocarbon-dated late Holocene sediments from Wallywash Great Pond, a small, shallow freshwater lake in southwestern Jamaica, to reconstruct limnological change over the past ∼ 1800 years. We circumvent ongoing taxonomic and ecological uncertainties associated with the identification of fossil ostracod taxa by drawing on observations of the ecology of ostracods found living in Jamaican water bodies. By combining this information with limnological data from the extant lake, and with sedimentological and isotopic data from the lake sediments, we show that a published interpretation of ostracod assemblages for the late Quaternary of Wallywash Great Pond is simplistic, at least for the late Holocene section of the sediment record. We conclude that changes in ostracod assemblages are linked to variations in the input of undersaturated groundwater to the northern part of the lake from which the core was recovered. These variations, which were driven by changes in the precipitation / evaporation ratio (effective moisture), also controlled sedimentation, with reduced effective moisture and a decline in undersaturated groundwater input favouring marl precipitation, whereas organic sediments are linked to increased effective moisture and enhanced groundwater input. Our findings suggest that the dramatic shifts in ostracod assemblages at this site are a complex response to changes in hydrology, sedimentology, and carbonate saturation rather than being a simple indicator of lake-level change. Combining ostracod assemblage data with the results of other palaeolimnological analyses also allows more detailed reconstructions to be made for this lake, and such a multiproxy approach is recommended for similar lakes elsewhere.
- Published
- 2024
- Full Text
- View/download PDF
15. A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization's Role as a Treatment Modality.
- Author
-
Lewis, Stanley T, Greenway, Frank, Tucker, Tori R, Alexander, Michael, Jackson, Levonika K, Hepford, Scott A, Loveridge, Brian, and Lakey, Jonathan RT
- Subjects
Humans ,Diabetes Mellitus ,Type 2 ,Insulin Resistance ,Insulin ,Blood Glucose ,Ligands ,Insulin ,Regular ,Human ,T2D ,carbohydrate metabolism ,diabetes ,insulin resistance ,physiologic insulin resensitization ,Clinical Research ,Diabetes ,Prevention ,Metabolic and endocrine ,Other Chemical Sciences ,Genetics ,Other Biological Sciences ,Chemical Physics - Abstract
Physiologic insulin secretion consists of an oscillating pattern of secretion followed by distinct trough periods that stimulate ligand and receptor activation. Apart from the large postprandial bolus release of insulin, β cells also secrete small amounts of insulin every 4-8 min independent of a meal. Insulin resistance is associated with a disruption in the normal cyclical pattern of insulin secretion. In the case of type-2 diabetes, β-cell mass is reduced due to apoptosis and β cells secrete insulin asynchronously. When ligand/receptors are constantly exposed to insulin, a negative feedback loop down regulates insulin receptor availability to insulin, creating a relative hyperinsulinemia. The relative excess of insulin leads to insulin resistance (IR) due to decreased receptor availability. Over time, progressive insulin resistance compromises carbohydrate metabolism, and may progress to type-2 diabetes (T2D). In this review, we discuss insulin resistance pathophysiology and the use of dynamic exogenous insulin administration in a manner consistent with more normal insulin secretion periodicity to reverse insulin resistance. Administration of insulin in such a physiologic manner appears to improve insulin sensitivity, lower HgbA1c, and, in some instances, has been associated with the reversal of end-organ damage that leads to complications of diabetes. This review outlines the rationale for how the physiologic secretion of insulin orchestrates glucose metabolism, and how mimicking this secretion profile may serve to improve glycemic control, reduce cellular inflammation, and potentially improve outcomes in patients with diabetes.
- Published
- 2023
16. Researching COVID to enhance recovery (RECOVER) adult study protocol: Rationale, objectives, and design
- Author
-
Horwitz, Leora I, Thaweethai, Tanayott, Brosnahan, Shari B, Cicek, Mine S, Fitzgerald, Megan L, Goldman, Jason D, Hess, Rachel, Hodder, SL, Jacoby, Vanessa L, Jordan, Michael R, Krishnan, Jerry A, Laiyemo, Adeyinka O, Metz, Torri D, Nichols, Lauren, Patzer, Rachel E, Sekar, Anisha, Singer, Nora G, Stiles, Lauren E, Taylor, Barbara S, Ahmed, Shifa, Algren, Heather A, Anglin, Khamal, Aponte-Soto, Lisa, Ashktorab, Hassan, Bassett, Ingrid V, Bedi, Brahmchetna, Bhadelia, Nahid, Bime, Christian, Bind, Marie-Abele C, Black, Lora J, Blomkalns, Andra L, Brim, Hassan, Castro, Mario, Chan, James, Charney, Alexander W, Chen, Benjamin K, Chen, Li Qing, Chen, Peter, Chestek, David, Chibnik, Lori B, Chow, Dominic C, Chu, Helen Y, Clifton, Rebecca G, Collins, Shelby, Costantine, Maged M, Cribbs, Sushma K, Deeks, Steven G, Dickinson, John D, Donohue, Sarah E, Durstenfeld, Matthew S, Emery, Ivette F, Erlandson, Kristine M, Facelli, Julio C, Farah-Abraham, Rachael, Finn, Aloke V, Fischer, Melinda S, Flaherman, Valerie J, Fleurimont, Judes, Fonseca, Vivian, Gallagher, Emily J, Gander, Jennifer C, Gennaro, Maria Laura, Gibson, Kelly S, Go, Minjoung, Goodman, Steven N, Granger, Joey P, Greenway, Frank L, Hafner, John W, Han, Jenny E, Harkins, Michelle S, Hauser, Kristine SP, Heath, James R, Hernandez, Carla R, Ho, On, Hoffman, Matthew K, Hoover, Susan E, Horowitz, Carol R, Hsu, Harvey, Hsue, Priscilla Y, Hughes, Brenna L, Jagannathan, Prasanna, James, Judith A, John, Janice, Jolley, Sarah, Judd, SE, Juskowich, Joy J, Kanjilal, Diane G, Karlson, Elizabeth W, Katz, Stuart D, Kelly, J Daniel, Kelly, Sara W, Kim, Arthur Y, Kirwan, John P, Knox, Kenneth S, Kumar, Andre, Lamendola-Essel, Michelle F, Lanca, Margaret, Lee-lannotti, Joyce K, Lefebvre, R Craig, and Levy, Bruce D
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Prevention ,Clinical Research ,Emerging Infectious Diseases ,Infectious Diseases ,Infection ,Good Health and Well Being - Abstract
Abstract: Importance: SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or other health effects after the acute phase of infection; termed post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID. The characteristics, prevalence, trajectory and mechanisms of PASC are ill-defined. The objectives of the Researching COVID to Enhance Recovery (RECOVER) Multi-site Observational Study of PASC in Adults (RECOVER-Adult) are to: (1) characterize PASC prevalence; (2) characterize the symptoms, organ dysfunction, natural history, and distinct phenotypes of PASC; (3) identify demographic, social and clinical risk factors for PASC onset and recovery; and (4) define the biological mechanisms underlying PASC pathogenesis. Methods: RECOVER-Adult is a combined prospective/retrospective cohort currently planned to enroll 14,880 adults aged ≥18 years. Eligible participants either must meet WHO criteria for suspected, probable, or confirmed infection; or must have evidence of no prior infection. Recruitment occurs at 86 sites in 33 U.S. states, Washington, DC and Puerto Rico, via facility– and community-based outreach. Participants complete quarterly questionnaires about symptoms, social determinants, vaccination status, and interim SARS-CoV-2 infections. In addition, participants contribute biospecimens and undergo physical and laboratory examinations at approximately 0, 90 and 180 days from infection or negative test date, and yearly thereafter. Some participants undergo additional testing based on specific criteria or random sampling. Patient representatives provide input on all study processes. The primary study outcome is onset of PASC, measured by signs and symptoms. A paradigm for identifying PASC cases will be defined and updated using supervised and unsupervised learning approaches with cross– validation. Logistic regression and proportional hazards regression will be conducted to investigate associations between risk factors, onset, and resolution of PASC symptoms. Discussion: RECOVER-Adult is the first national, prospective, longitudinal cohort of PASC among US adults. Results of this study are intended to inform public health, spur clinical trials, and expand treatment options.
- Published
- 2023
17. Context is a Critical for Psychoactive Drug Effects
- Author
-
Greenway, Kyle T.
- Published
- 2023
- Full Text
- View/download PDF
18. Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
- Author
-
Garel, Nicolas, Greenway, Kyle T., Dinh-Williams, Lê-Anh L., Thibault-Levesque, Julien, Jutras-Aswad, Didier, Turecki, Gustavo, Rej, Soham, and Richard-Devantoy, Stephane
- Published
- 2023
- Full Text
- View/download PDF
19. It Takes a Village: Leveraging a Multidisciplinary Team and Technology for Urine Culturing Stewardship
- Author
-
Mandy Swann, Amy Lucas, Christian Ostrowski, Carla Bapst, Lauren Fargis, Robin Strachman, Kathleen Manchin, Maribeth Greenway, Jacob Gillen, and Anthony Baffoe-Bonnie
- Subjects
Infectious and parasitic diseases ,RC109-216 ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Patients without urinary tract infection (UTI) symptoms but with a positive urine culture are considered to have asymptomatic bacteriuria (ASB). This often represents colonization and treatment is not recommended or clinically beneficial. Treatment of ASB can promote antimicrobial resistance and increased rates of Clostriodies difficile infections. Many cases of ASB are incorrectly assigned as CAUTIs due to over-culturing practices. We hypothesized that a urine culture algorithm, embedded within a best practice alert (BPA) in the electronic medical record (EMR), would reduce urine culturing practices for ASB. Methods: From Feb 2022 through May 2023, a multidisciplinary team implemented an Inpatient Urine Culturing Stewardship Guideline. A BPA fired when a provider placed a urinalysis with reflex to culture (UACC) or urine culture (UC) order for patients who met criteria (Image 1). The BPA directed providers to remove the order, select the appropriate pathway from the guideline, or provide a rationale for placing the order. The intervention was piloted on three intensive care units and two progressive care units, containing both medical and surgical patients. Monthly ordering practices, CAUTI rates, and gram-negative rod (GNR) bacteremia rates from a 13-month pre-intervention baseline period were compared to a 16-month intervention period. Over the same time periods, we also assessed changes in ordering practices for comparison units which did not implement the intervention. Pre-and-post intervention cohorts were analyzed using median two sample tests and Exact Poison Method, as appropriate. Results: On intervention units there was a 41.0% reduction in the median number of UACC and UC orders per 1000 patient days from 16.31 during the baseline period to 9.62 in the intervention period (p=0.0036). Pan cultures per 1000 patient days in which one of the orders was a UACC or UC fell by 42.2% from a median of 10.20 per 1000 patient days to 5.90 (p=0.0008). The comparison units saw no significant reductions in UACC and UC orders (p=0.21) or pan cultures (p=1.0). On the intervention units, the CAUTI rate for the baseline period was 1.31 per 1000 catheter days versus 0.79 in the intervention period (IRR = 1.65; p=0.44). GNR bacteremias remained stable on the intervention units between the baseline and intervention periods (p=0.82). Conclusion: This multidisciplinary intervention, leveraging EMR clinical decision support, reduced urine and pan culturing practices while demonstrating a trend towards a reduced CAUTI rate. The prevalence of GNR bacteremias remained consistent with baseline levels, suggesting the intervention did not cause harm.
- Published
- 2024
- Full Text
- View/download PDF
20. Treatment of RAF1-Related Obstructive Hypertrophic Cardiomyopathy by MEK Inhibition Using Trametinib
- Author
-
Omid Kiamanesh, MD, Steven C. Greenway, MD, Franciscus Dicke, MD, MBA, Brennan Ballantyne, MD, Sasha Mitrovic, RDCS, Kaitlin McGrath, MD, James A. White, MD, William D.T. Kent, MD, and Gregor Andelfinger, MD
- Subjects
cardiovascular genetics ,hypertrophic cardiomyopathy ,Noonan syndrome ,RASopathies ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
RASopathies cause nonsarcomeric hypertrophic cardiomyopathy via dysregulated signaling through RAS and upregulated mitogen-activated protein kinase activity. We provide the first report of the successful treatment of an adult with RAF1-associated hypertrophic cardiomyopathy using trametinib, a MEK inhibitor.
- Published
- 2024
- Full Text
- View/download PDF
21. A Systematic Review of Uremic Toxin Concentrations and Cardiovascular Risk Markers in Pediatric Chronic Kidney Disease
- Author
-
Heshini Dalpathadu, Aly Muhammad Salim, Andrew Wade, and Steven C. Greenway
- Subjects
cardiorenal syndrome ,uremic toxin ,uremic solute ,uremic cardiomyopathy ,cardiac toxicity ,chronic kidney disease ,Medicine - Abstract
Chronic kidney disease (CKD) can lead to cardiac dysfunction in a condition known as cardiorenal syndrome (CRS). It is postulated that the accumulation of uremic toxins in the bloodstream, as a consequence of declining kidney function, may contribute to these adverse cardiac effects. While CRS in adults has been extensively studied, there is a significant knowledge gap with pediatric patients. Uremic toxin levels in children remain inadequately characterized and quantified compared to adults. This review aims to systematically evaluate the association between uremic toxin concentrations and cardiac changes in pediatric CRS and to examine the impact of different dialysis modalities, specifically hemodialysis and peritoneal dialysis, on uremic toxin clearance and cardiovascular parameters. To address this, we conducted a systematic literature search of PubMed, following PRISMA guidelines. We used the terms “uremic toxins” and “cardiorenal syndrome” with variations in syntax to search for studies discussing the relationship between uremic toxin levels in CKD, the subsequent impact on cardiac parameters, and the emergence of cardiac dysfunction. Full-text articles written in English, conducted on humans aged from birth to 18 years, and published until December 2021 were included. A comprehensive literature search yielded six studies, and their risk of bias was assessed using JBI Critical Appraisal Checklists. Our systematic review is registered on PROSPERO, number CRD42023460072. This synthesis intends to provide an understanding of the role of uremic toxins in pediatric CRS. The findings reveal that pediatric patients with end-stage CKD on dialysis exhibit elevated uremic toxin levels, which are significantly associated with cardiovascular disease parameters. Additionally, the severity of CKD correlated with higher uremic toxin levels. No conclusive evidence was found to support the superiority of either hemodialysis or peritoneal dialysis in terms of uremic toxin clearance or cardiovascular outcomes. More pediatric-specific standardized and longitudinal studies are needed to develop targeted treatments and improve clinical outcomes and the quality of life for affected children.
- Published
- 2024
- Full Text
- View/download PDF
22. The Effect of Social Devaluation, Labeling, and Familiarity on Children's Attitudes and Behavioral Intentions toward a Peer with Symptoms of ADHD
- Author
-
Greenway, Charlotte W., Robinson, Ammanys H., and King, Janice M.
- Abstract
The present study examined the attitudes and behavioral intentions of 336 children aged 7-11 toward a hypothetical peer with symptoms of attention-deficit hyperactivity disorder (ADHD) to determine whether they were influenced by labeling, social devaluation, or familiarity. Children read one of five vignettes describing the behavior of a gender-neutral peer before completing self-report measures of attitudes and behavioral intentions. Results showed children held predominantly negative attitudes toward the hypothetical peer, which were more pronounced for inattentive than hyperactive/impulsive symptoms. These findings suggest that children were more likely to devalue internalizing rather than externalizing behaviors. Children also reported being more likely to engage in active/recreational and social activities rather than academic activities. In addition, the diagnostic label "ADHD" led to more negative attitudes and behavioral intentions, while knowing someone with ADHD mediated the negative effect of hyperactive/impulsive symptoms on attitudes and behavioral intentions. Finally, significant positive relationships were found between attitudes and children's willingness to engage in social, academic, and physical activities. Policy and practice implications of these findings are discussed.
- Published
- 2023
- Full Text
- View/download PDF
23. The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
- Author
-
Höchsmann, Christoph, Yang, Shengping, Ordovás, José M., Dorling, James L., Champagne, Catherine M., Apolzan, John W., Greenway, Frank L., Cardel, Michelle I., Foster, Gary D., and Martin, Corby K.
- Published
- 2023
- Full Text
- View/download PDF
24. A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic control
- Author
-
Apolzan, John W., LaRose, Jessica Gokee, Anton, Stephen D., Beyl, Robbie A., Greenway, Frank L., Wickham, III, Edmond P., Lanoye, Autumn, Harris, Melissa N., Martin, Corby K., Bullard, Tiffany, Foster, Gary D., and Cardel, Michelle I.
- Published
- 2023
- Full Text
- View/download PDF
25. Erratum to: Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes
- Author
-
Piers Blombery, Lucy Fox, Georgina L. Ryland, Ella R. Thompson, Jennifer Lickiss, Michelle McBean, Satwica Yerneni, Alison Trainer, David Hughes, Anthea Greenway, Francoise Mechinaud, Erica M. Wood, Graham J. Lieschke, Jeff Szer, Pasquale Barbaro, John Roy, Joel Wight, Elly Lynch, Melissa Martyn, Clara Gaff, and David Ritchie
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2024
- Full Text
- View/download PDF
26. A cross-sectional review of contact allergens in popular self-tanning products
- Author
-
Jazmin Newton, MD, Oluwafunke Ogunremi, BS, Riley T. Paulsen, PhD, Molly Lien, BS, Meaghan Sievers, BSN, and Mandi Greenway Bietz, MD
- Subjects
Dermatology ,RL1-803 - Abstract
Background:. In recent years, self-tanners have become a well-liked alternative to sun tanning and tanning bed usage, as strikingly similar results can be achieved without the harmful side effects of ultraviolet exposure. Objective:. The aim of this study is to investigate the presence and prevalence of potential allergens in the most popular self-tanning products. Methods:. Five major retailers in the United States were evaluated, from which 17 different brands and 44 unique self-tanning products were analyzed. The ingredients in each self-tanning product were compared with 80 and 36 notable contact allergens taken from the North American Contact Dermatitis Group and Food and Drug Administration–approved T.R.U.E (Thin-Layer Rapid Use Epicutaneous Patch Test), respectively. Results:. We found that contact allergens are frequently present in self-tanning products; allergens especially common are propylene glycol, linalool, polysorbate, d-limonene, benzyl alcohol, tocopherol (vitamin E), fragrances, and other scented botanicals. On average, each self-tanner we analyzed contained 11.86 allergens. Limitations:. The limitation is that commercial names could not be eliminated from the analysis, introducing potential bias. Conclusion:. While self-tanning products are a safer alternative to tanning bed use or sunbathing, consumers and clinicians alike must be aware that they may cause an allergic reaction of the skin for some users.
- Published
- 2024
- Full Text
- View/download PDF
27. The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
- Author
-
Christoph Höchsmann, Shengping Yang, José M. Ordovás, James L. Dorling, Catherine M. Champagne, John W. Apolzan, Frank L. Greenway, Michelle I. Cardel, Gary D. Foster, and Corby K. Martin
- Subjects
Science - Abstract
Abstract Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa for fat-responsive genotypes). We investigated whether 12-week WL (kg, primary outcome) differs between genotype-concordant and genotype-discordant diets. In this 12-week single-center WL trial, 145 participants with overweight/obesity were identified a priori as fat-responders or carbohydrate-responders based on their combined genotypes at ten genetic variants and randomized to a high-fat (n = 73) or high-carbohydrate diet (n = 72), yielding 4 groups: (1) fat-responders receiving high-fat diet, (2) fat-responders receiving high-carbohydrate diet, (3) carbohydrate-responders receiving high-fat diet, (4) carbohydrate-responders receiving high-carbohydrate diet. Dietitians delivered the WL intervention via 12 weekly diet-specific small group sessions. Outcome assessors were blind to diet assignment and genotype patterns. We included 122 participants (54.4 [SD:13.2] years, BMI 34.9 [SD:5.1] kg/m2, 84% women) in the analyses. Twelve-week WL did not differ between the genotype-concordant (−5.3 kg [SD:1.0]) and genotype-discordant diets (−4.8 kg [SD:1.1]; adjusted difference: −0.6 kg [95% CI: −2.1,0.9], p = 0.50). With the current ability to genotype participants as fat- or carbohydrate-responders, evidence does not support greater WL on genotype-concordant diets. ClinicalTrials identifier: NCT04145466.
- Published
- 2023
- Full Text
- View/download PDF
28. Effect of exercise training on insulin-stimulated glucose disposal: a systematic review and meta-analysis of randomized controlled trials
- Author
-
Rebello, Candida J., Zhang, Dachuan, Kirwan, John P., Lowe, Adam C., Emerson, Carlante J., Kracht, Chelsea L., Steib, Lori C., Greenway, Frank L., Johnson, William D., and Brown, Justin C.
- Published
- 2023
- Full Text
- View/download PDF
29. Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology
- Author
-
Greenway, Frank, Loveridge, Brian, Grimes, Richard M, Tucker, Tori R, Alexander, Michael, Hepford, Scott A, Fontenot, Justin, Nobles-James, Candi, Wilson, Carol, Starr, Adam M, Abdelsaid, Mohammed, Lewis, Stanley T, and Lakey, Jonathan RT
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Medicinal and Biomolecular Chemistry ,Chemical Sciences ,Microbiology ,Diabetes ,Metabolic and endocrine ,Diabetes Mellitus ,Type 2 ,Glycated Hemoglobin ,Humans ,Insulin Resistance ,Insulin Secretion ,Insulin ,Regular ,Human ,Pancreas ,insulin resistance ,diabetes ,metabolic disorder ,obesity ,insulin infusion ,physiologic insulin resensitization ,PIR ,treatment modality ,neuropathy ,nephropathy ,retinopathy ,cardiovascular disease ,chronic kidney disease ,CKD ,Other Chemical Sciences ,Genetics ,Other Biological Sciences ,Chemical Physics ,Biochemistry and cell biology ,Medicinal and biomolecular chemistry - Abstract
Prevalence of type 2 diabetes increased from 2.5% of the US population in 1990 to 10.5% in 2018. This creates a major public health problem, due to increases in long-term complications of diabetes, including neuropathy, retinopathy, nephropathy, skin ulcers, amputations, and atherosclerotic cardiovascular disease. In this review, we evaluated the scientific basis that supports the use of physiologic insulin resensitization. Insulin resistance is the primary cause of type 2 diabetes. Insulin resistance leads to increasing insulin secretion, leading to beta-cell exhaustion or burnout. This triggers a cascade leading to islet cell destruction and the long-term complications of type 2 diabetes. Concurrent with insulin resistance, the regular bursts of insulin from the pancreas become irregular. This has been treated by the precise administration of insulin more physiologically. There is consistent evidence that this treatment modality can reverse the diabetes-associated complications of neuropathy, diabetic ulcers, nephropathy, and retinopathy, and that it lowers HbA1c. In conclusion, physiologic insulin resensitization has a persuasive scientific basis, significant treatment potential, and likely cost benefits.
- Published
- 2022
30. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
- Author
-
Lee, Christine G, Heckman-Stoddard, Brandy, Dabelea, Dana, Gadde, Kishore M, Ehrmann, David, Ford, Leslie, Prorok, Philip, Boyko, Edward J, Pi-Sunyer, Xavier, Wallia, Amisha, Knowler, William C, Crandall, Jill P, Temprosa, Marinella, Group:, Diabetes Prevention Program Research, Bray, George A, Culbert, Iris W, Arceneaux, Jennifer, Chatellier, Annie, Dragg, Amber, Champagne, Catherine M, Duncan, Crystal, Eberhardt, Barbara, Greenway, Frank, Guillory, Fonda G, Herbert, April A, Jeffirs, Michael L, Kennedy, Betty M, Levy, Erma, Lockett, Monica, Lovejoy, Jennifer C, Morris, Laura H, Melancon, Lee E, Ryan, Donna H, Sanford, Deborah A, Smith, Kenneth G, Smith, Lisa L, St. Amant, Julia A, Tulley, Richard T, Vicknair, Paula C, Williamson, Donald, Zachwieja, Jeffery J, Polonsky, Kenneth S, Tobian, Janet, Ehrmann, David A, Matulik, Margaret J, Temple, Karla A, Clark, Bart, Czech, Kirsten, DeSandre, Catherine, Dotson, Brittnie, Hilbrich, Ruthanne, McNabb, Wylie, Semenske, Ann R, Caro, Jose F, Furlong, Kevin, Goldstein, Barry J, Watson, Pamela G, Smith, Kellie A, Mendoza, Jewel, Simmons, Marsha, Wildman, Wendi, Liberoni, Renee, Spandorfer, John, Pepe, Constance, Donahue, Richard P, Goldberg, Ronald B, Prineas, Ronald, Calles, Jeanette, Giannella, Anna, Rowe, Patricia, Sanguily, Juliet, Cassanova-Romero, Paul, Castillo-Florez, Sumaya, Florez, Hermes J, Garg, Rajesh, Kirby, Lascelles, Lara, Olga, Larreal, Carmen, McLymont, Valerie, Mendez, Jadell, Perry, Arlette, Saab, Patrice, Veciana, Bertha, Haffner, Steven M, Hazuda, Helen P, Montez, Maria G, Hattaway, Kathy, Isaac, Juan, Lorenzo, Carlos, Martinez, Arlene, Salazar, Monica, Walker, Tatiana, Hamman, Richard F, Nash, Patricia V, Steinke, Sheila C, Testaverde, Lisa, Truong, Jennifer, and Anderson, Denise R
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Clinical Sciences ,Prevention ,Clinical Trials and Supportive Activities ,Nutrition ,Clinical Research ,Cancer ,Cardiovascular ,Diabetes ,Aetiology ,2.2 Factors relating to the physical environment ,Good Health and Well Being ,Adult ,Cardiovascular Diseases ,Diabetes Mellitus ,Type 2 ,Humans ,Hypoglycemic Agents ,Life Style ,Metformin ,Diabetes Prevention Program Research Group ,Diabetes Prevention Program Research Group: ,Medical and Health Sciences ,Endocrinology & Metabolism ,Biomedical and clinical sciences ,Health sciences - Abstract
ObjectiveTo determine whether metformin or lifestyle modification can lower rates of all-cause and cause-specific mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.Research design and methodsFrom 1996 to 1999, 3,234 adults at high risk for type 2 diabetes were randomized to an intensive lifestyle intervention, masked metformin, or placebo. Placebo and lifestyle interventions stopped in 2001, and a modified lifestyle program was offered to everyone, but unmasked study metformin continued in those originally randomized. Causes of deaths through 31 December 2018 were adjudicated by blinded reviews. All-cause and cause-specific mortality hazard ratios (HRs) were estimated from Cox proportional hazards regression models and Fine-Gray models, respectively.ResultsOver a median of 21 years (interquartile range 20-21), 453 participants died. Cancer was the leading cause of death (n = 170), followed by cardiovascular disease (n = 131). Compared with placebo, metformin did not influence mortality from all causes (HR 0.99 [95% CI 0.79, 1.25]), cancer (HR 1.04 [95% CI 0.72, 1.52]), or cardiovascular disease (HR 1.08 [95% CI 0.70, 1.66]). Similarly, lifestyle modification did not impact all-cause (HR 1.02 [95% CI 0.81, 1.28]), cancer (HR 1.07 [95% CI 0.74, 1.55]), or cardiovascular disease (HR 1.18 [95% CI 0.77, 1.81]) mortality. Analyses adjusted for diabetes status and duration, BMI, cumulative glycemic exposure, and cardiovascular risks yielded results similar to those for all-cause mortality.ConclusionsCancer was the leading cause of mortality among adults at high risk for type 2 diabetes. Although metformin and lifestyle modification prevented diabetes, neither strategy reduced all-cause, cancer, or cardiovascular mortality rates.
- Published
- 2021
31. Near-Surface Thermodynamic Influences on Evaporation Duct Shape
- Author
-
Sarah E. Wessinger, Daniel P. Greenway, Tracy Haack, and Erin E. Hackett
- Subjects
evaporation ducts ,evaporation duct shape ,log-linear refractivity models ,refractivity parameterization ,refractivity ,specific humidity ,Meteorology. Climatology ,QC851-999 - Abstract
This study utilizes in situ measurements and numerical weather prediction forecasts curated during the Coupled Air–Sea Processes Electromagnetic Ducting Research (CASPER) east field campaign to assess how thermodynamic properties in the marine atmospheric surface layer influence evaporation duct shape independent of duct height. More specifically, we investigate evaporation duct shape through a duct shape parameter, a parameter known to affect the propagation of X-band radar signals and is directly related to the curvature of the duct. Relationships between this duct shape parameter and air sea temperature difference (ASTD) reveal that during unstable periods (ASTD < 0), the duct shape parameter is generally larger than in near-neutral or stable atmospheric conditions, indicating tighter curvature of the M-profile. Furthermore, for any specific duct height, a strong linear relationship between the near-surface-specific humidity gradient and the duct shape parameter is found, suggesting that it is primarily driven by near-surface humidity gradients. The results demonstrate that an a priori estimate of duct shape, for a given duct height, is possible if the near-surface humidity gradient is known.
- Published
- 2024
- Full Text
- View/download PDF
32. A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic control
- Author
-
John W. Apolzan, Jessica Gokee LaRose, Stephen D. Anton, Robbie A. Beyl, Frank L. Greenway, Edmond P. Wickham, Autumn Lanoye, Melissa N. Harris, Corby K. Martin, Tiffany Bullard, Gary D. Foster, and Michelle I. Cardel
- Subjects
Nutritional diseases. Deficiency diseases ,RC620-627 - Abstract
Abstract Background The objective was to test the efficacy of a scalable, virtually delivered, diabetes-tailored weight management program on glycemic control in adults with type 2 diabetes (T2D). Methods This was a single arm, three-site clinical trial. Participants had baseline HbA1c between 7–11% and BMI between 27–50 kg/m2. Primary outcome was change in HbA1c at 24 weeks. Secondary outcomes were changes in body weight, waist circumference, the Diabetes Distress Scale (DDS), quality of life (IWQOL-L), and hunger (VAS). Generalized linear effects models were used for statistical analysis. Results Participants (n = 136) were 56.8 ± 0.8 y (Mean ± SEM), 36.9 ± 0.5 kg/m2, 80.2% female, 62.2% non-Hispanic white. Baseline HbA1c, weight, and total DDS score were 8.0 ± 0.09%, 101.10 ± 1.47 kg, and 2.35 ± 0.08, respectively. At week 24, HbA1c, body weight, and total DDS decreased by 0.75 ± 0.11%, 5.74 ± 0.50%, 0.33 ± 0.10 units, respectively (all p
- Published
- 2023
- Full Text
- View/download PDF
33. Countertransference towards suicidal patients: a systematic review
- Author
-
Michaud, Laurent, Greenway, Kyle T., Corbeil, Sylvie, Bourquin, Céline, and Richard-Devantoy, Stéphane
- Published
- 2023
- Full Text
- View/download PDF
34. Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program
- Author
-
Aroda, Vanita R, Christophi, Costas A, Edelstein, Sharon L, Perreault, Leigh, Kim, Catherine, Golden, Sherita H, Horton, Edward, Mather, Kieren J, Bray, George A, Gadde, Kishore, Culbert, Iris W, Arceneaux, Jennifer, Chatellier, Annie, Dragg, Amber, Champagne, Catherine M, Duncan, Crystal, Eberhardt, Barbara, Greenway, Frank, Guillory, Fonda G, Herbert, April A, Jeffirs, Michael L, Kennedy, Betty M, Levy, Erma, Lockett, Monica, Lovejoy, Jennifer C, Morris, Laura H, Melancon, Lee E, Ryan, Donna H, Sanford, Deborah A, Smith, Kenneth G, Smith, Lisa L, St, Julia A, Amant, Richard T Tulley, Vicknair, Paula C, Williamson, Donald, Zachwieja, Jeffery J, Polonsky, Kenneth S, Tobian, Janet, Ehrmann, David A, Matulik, Margaret J, Clark, Bart, Czech, Kirsten, DeSandre, Catherine, Hilbrich, Ruthanne, McNabb, Wylie, Semenske, Ann R, Caro, Jose F, Furlong, Kevin, Goldstein, Barry J, Watson, Pamela G, Smith, Kellie A, Mendoza, Jewel, Wildman, Wendi, Liberoni, Renee, Spandorfer, John, Pepe, Constance, Donahue, Richard P, Goldberg, Ronald B, Prineas, Ronald, Calles, Jeanette, Ojito, Juliet, Rowe, Patricia, Cassanova-Romero, Paul, Castillo-Florez, Sumaya, Florez, Hermes J, Giannella, Anna, Kirby, Lascelles, Larreal, Carmen, Lara, Olga, McLymont, Valerie, Mendez, Jadell, Perry, Arlette, Saab, Patrice, Veciana, Beth, Haffner, Steven M, Hazuda, Helen P, Montez, Maria G, Hattaway, Kathy, Lorenzo, Carlos, Martinez, Arlene, Walker, Tatiana, Dabelea, Dana, Hamman, Richard F, Nash, Patricia V, Steinke, Sheila C, Testaverde, Lisa, Anderson, Denise R, Ballonoff, Larry B, Bouffard, Alexis, Bucca, Brian, Calonge, B Ned, Delve, Lynne, Farago, Martha, Hill, James O, Hoyer, Shelley R, Jenkins, Tonya, Jortberg, Bonnie T, Lenz, Dione, and Miller, Marsha
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Diabetes ,Cardiovascular ,Obesity ,Estrogen ,Clinical Research ,Prevention ,Nutrition ,Aging ,Clinical Trials and Supportive Activities ,3.1 Primary prevention interventions to modify behaviours or promote wellbeing ,Prevention of disease and conditions ,and promotion of well-being ,Metabolic and endocrine ,Diabetes Mellitus ,Type 2 ,Female ,Glucose Intolerance ,Humans ,Life Style ,Male ,Metformin ,Sex Hormone-Binding Globulin ,DPP Research Group ,diabetes mellitus ,hormone ,life style ,primary prevention ,type 2 ,Clinical sciences ,Public health - Abstract
Sex hormone binding globulin (SHBG) levels are reported to be inversely associated with diabetes risk. It is unknown whether diabetes prevention interventions increase SHBG and whether resultant changes in SHBG affect diabetes risk. The purpose of this analysis was to determine whether intensive lifestyle intervention (ILS) or metformin changed circulating SHBG and if resultant changes influenced diabetes risk in the Diabetes Prevention Program (DPP). This is a secondary analysis from the DPP (1996-2001), a randomized trial of ILS or metformin versus placebo on diabetes risk over a mean follow-up of 3.2 years. The DPP was conducted across 27 academic study centers in the USA. Men, premenopausal and postmenopausal women without hormone use in the DPP were evaluated. The DPP included overweight/obese persons with elevated fasting glucose and impaired glucose tolerance. Main outcomes measures were changes in SHBG levels at 1 year and risk of diabetes over 3 years. ILS resulted in significantly higher increases (postmenopausal women: p
- Published
- 2020
35. Why does the Matador Bug, Anisoscelis alipes (Hemiptera: Coreidae), Wave its Brightly Colored Legs?
- Author
-
Longbottom, Cameron, Falk, Jay J., Greenway, E.V(Ginny), Johnson, Meredith G., Ramos, Christian, Rößler, Daniela C., Rubin, Juliette J., and Somjee, Ummat
- Published
- 2022
- Full Text
- View/download PDF
36. Resisting Indifference through the Brooch of Bergen Belsen
- Author
-
Greenway, Kate
- Abstract
In this extract from, and commentary on, my master's thesis, "The Brooch of Bergen Belsen: A Journey of Historiographic Poiesis" (winning York University Department of Education Best Major Research Paper 2010), I explore a single aesthetic experience, an encounter with a small hand-made floral cloth brooch donated to the Holocaust Memorial Museum. At the start of my inquiry, I had only the object--the brooch itself--my emotional reaction to it, and the few lines of text on a curated museum card. I wondered, how do we create "spaces for remembrance" (Simon 2005) and what are the implications for teaching, learning and living in a just society? How are we accountable to Simon's (2004) demand for "non-indifference?" Arts-based research methodologies such as historiographic poiesis have allowed me to merge the scholar and artist, to engage in research as an iterative process where deeper questions engender more complex and embodied responses, and to create an aesthetic intervention: an open, dialogic text and artworks that provoke new understandings of narratives previously overlooked.
- Published
- 2018
37. Common pathway coagulopathy and hemorrhagic edema of infancy
- Author
-
Jye Gard, Raffaela Armiento, Anna Cartwright, Shelley Bell, Anthea Greenway, and Erin O'Reilly
- Subjects
bleeding ,dyscrasias ,edema ,microangiopathy ,pediatrics ,Medicine ,Medicine (General) ,R5-920 - Abstract
Key Clinical Message When screening tests of haemostasis are abnormal, it is important to identify at which point in the coagulation cascade dysfunction may be occurring. This may assist to identify a specific deficiency/dysfunction, the type of bleeding to be anticipated, and replacement therapy if required. Unmasking of an inherited coagulopathy or the development of an acquired coagulopathy may occur in the setting of a second (febrile) illness. Differentiating between inherited and acquired coagulopathies will rely on clinicians taking a thorough personal and family bleeding history, and correlating these findings with the haemostasis screening results.
- Published
- 2023
- Full Text
- View/download PDF
38. The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
- Author
-
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, Nathalie Goyette, Alexandre Lehmann, Karl Looper, David Erritzoe, Shannon Dames, Gustavo Turecki, Soham Rej, Stephane Richard-Devantoy, and Kyle T. Greenway
- Subjects
ketamine ,psychedelics ,depression ,pharmacology ,psychotherapy ,implementation science ,Psychiatry ,RC435-571 - Abstract
BackgroundSubanesthetic ketamine has accumulated meta-analytic evidence for rapid antidepressant effects in treatment-resistant depression (TRD), resulting in both excitement and debate. Many unanswered questions surround ketamine’s mechanisms of action and its integration into real-world psychiatric care, resulting in diverse utilizations that variously resemble electroconvulsive therapy, conventional antidepressants, or serotonergic psychedelics. There is thus an unmet need for clinical approaches to ketamine that are tailored to its unique therapeutic properties.MethodsThis article presents the Montreal model, a comprehensive biopsychosocial approach to ketamine for severe TRD refined over 6 years in public healthcare settings. To contextualize its development, we review the evidence for ketamine as a biomedical and as a psychedelic treatment of depression, emphasizing each perspectives’ strengths, weaknesses, and distinct methods of utilization. We then describe the key clinical experiences and research findings that shaped the model’s various components, which are presented in detail.ResultsThe Montreal model, as implemented in a recent randomized clinical trial, aims to synergistically pair ketamine infusions with conventional and psychedelic biopsychosocial care. Ketamine is broadly conceptualized as a brief intervention that can produce windows of opportunity for enhanced psychiatric care, as well as powerful occasions for psychological growth. The model combines structured psychiatric care and concomitant psychotherapy with six ketamine infusions, administered with psychedelic-inspired nonpharmacological adjuncts including rolling preparative and integrative psychological support.DiscussionOur integrative model aims to bridge the biomedical-psychedelic divide to offer a feasible, flexible, and standardized approach to ketamine for TRD. Our learnings from developing and implementing this psychedelic-inspired model for severe, real-world patients in two academic hospitals may offer valuable insights for the ongoing roll-out of a range of psychedelic therapies. Further research is needed to assess the Montreal model’s effectiveness and hypothesized psychological mechanisms.
- Published
- 2023
- Full Text
- View/download PDF
39. Convergent evolution of conserved mitochondrial pathways underlies repeated adaptation to extreme environments
- Author
-
Greenway, Ryan, Barts, Nick, Henpita, Chathurika, Brown, Anthony P, Arias Rodriguez, Lenin, Rodríguez Peña, Carlos M, Arndt, Sabine, Lau, Gigi Y, Murphy, Michael P, Wu, Lei, Lin, Dingbo, Tobler, Michael, Kelley, Joanna L, and Shaw, Jennifer H
- Subjects
Climate Change Impacts and Adaptation ,Biological Sciences ,Evolutionary Biology ,Genetics ,Environmental Sciences ,Generic health relevance ,Adaptation ,Physiological ,Animals ,Ecosystem ,Evolution ,Molecular ,Extreme Environments ,Genome ,Hydrogen Sulfide ,Mitochondria ,Phylogeny ,Poecilia ,adaptive evolution ,comparative physiology ,ecological genomics ,hydrogen sulfide ,phylogenetic comparative analysis - Abstract
Extreme environments test the limits of life; yet, some organisms thrive in harsh conditions. Extremophile lineages inspire questions about how organisms can tolerate physiochemical stressors and whether the repeated colonization of extreme environments is facilitated by predictable and repeatable evolutionary innovations. We identified the mechanistic basis underlying convergent evolution of tolerance to hydrogen sulfide (H2S)-a toxicant that impairs mitochondrial function-across evolutionarily independent lineages of a fish (Poecilia mexicana, Poeciliidae) from H2S-rich springs. Using comparative biochemical and physiological analyses, we found that mitochondrial function is maintained in the presence of H2S in sulfide spring P. mexicana but not ancestral lineages from nonsulfidic habitats due to convergent adaptations in the primary toxicity target and a major detoxification enzyme. Genome-wide local ancestry analyses indicated that convergent evolution of increased H2S tolerance in different populations is likely caused by a combination of selection on standing genetic variation and de novo mutations. On a macroevolutionary scale, H2S tolerance in 10 independent lineages of sulfide spring fishes across multiple genera of Poeciliidae is correlated with the convergent modification and expression changes in genes associated with H2S toxicity and detoxification. Our results demonstrate that the modification of highly conserved physiological pathways associated with essential mitochondrial processes mediates tolerance to physiochemical stress. In addition, the same pathways, genes, and-in some instances-codons are implicated in H2S adaptation in lineages that span 40 million years of evolution.
- Published
- 2020
40. Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors
- Author
-
Merino, Jordi, Jablonski, Kathleen A, Mercader, Josep M, Kahn, Steven E, Chen, Ling, Harden, Maegan, Delahanty, Linda M, Araneta, Maria Rosario G, Walford, Geoffrey A, Jacobs, Suzanne BR, Ibebuogu, Uzoma N, Franks, Paul W, Knowler, William C, Florez, Jose C, Bray, George A, Gadde, Kishore, Chatellier, Annie, Arceneaux, Jennifer, Dragg, Amber, Duncan, Crystal, Greenway, Frank L, Hsia, Daniel, Levy, Erma, Lockett, Monica, Ryan, Donna H, Ehrmann, David, Matulik, Margaret J, Czech, Kirsten, DeSandre, Catherine, Goldstein, Barry J, Furlong, Kevin, Smith, Kellie A, Wildman, Wendi, Pepe, Constance, Goldberg, Ronald B, Calles, Jeanette, Ojito, Juliet, Castillo-Florez, Sumaya, Florez, Hermes J, Giannella, Anna, Lara, Olga, Veciana, Beth, Haffner, Steven M, Hazuda, Helen P, Montez, Maria G, Hattaway, Kathy, Lorenzo, Carlos, Martinez, Arlene, Walker, Tatiana, Hamman, Richard F, Dabelea, Dana, Testaverde, Lisa, Anderson, Denise, Bouffard, Alexis, Jenkins, Tonya, Lenz, Dione, Perreault, Leigh, Price, David W, Steinke, Sheila C, Horton, Edward S, Poirier, Catherine S, Swift, Kati, Caballero, Enrique, Fargnoli, Barbara, Guidi, Ashley, Guido, Mathew, Jackson, Sharon D, Lambert, Lori, Lawton, Kathleen E, Ledbury, Sarah, Sansoucy, Jessica, Spellman, Jeanne, Montgomery, Brenda K, Fujimoto, Wilfred, Knopp, Robert H, Lipkin, Edward W, Morgan-Taggart, Ivy, Murillo, Anne, Taylor, Lonnese, Thomas, April, Tsai, Elaine C, Trence, Dace, Kitabchi, Abbas E, Dagogo-Jack, Samuel, Murphy, Mary E, Taylor, Laura, Dolgoff, Jennifer, Clark, Debra, Ibebuogu, Uzoma, Lambeth, Helen, Ricks, Harriet, Rutledge, Lily MK, Soberman, Judith E, Molitch, Mark E, Metzger, Boyd E, Johnson, Mariana K, Giles, Mimi M, Larsen, Diane, and Pen, Samsam C
- Subjects
Biomedical and Clinical Sciences ,Diabetes ,Clinical Research ,Atherosclerosis ,Clinical Trials and Supportive Activities ,Cardiovascular ,Heart Disease ,Prevention ,Heart Disease - Coronary Heart Disease ,Nutrition ,Obesity ,Metabolic and endocrine ,Good Health and Well Being ,Adult ,Cardiovascular Diseases ,Coronary Artery Disease ,Diabetes Mellitus ,Type 2 ,Exercise ,Exercise Therapy ,Female ,Gene-Environment Interaction ,Genetic Predisposition to Disease ,Humans ,Life Style ,Male ,Metabolic Syndrome ,Metformin ,Middle Aged ,Prediabetic State ,Preventive Health Services ,Risk Factors ,United States ,Diabetes Prevention Program Research Group ,Medical and Health Sciences ,Endocrinology & Metabolism ,Biomedical and clinical sciences - Abstract
Coronary artery disease (CAD) is more frequent among individuals with dysglycemia. Preventive interventions for diabetes can improve cardiometabolic risk factors (CRFs), but it is unclear whether the benefits on CRFs are similar for individuals at different genetic risk for CAD. We built a 201-variant polygenic risk score (PRS) for CAD and tested for interaction with diabetes prevention strategies on 1-year changes in CRFs in 2,658 Diabetes Prevention Program (DPP) participants. We also examined whether separate lifestyle behaviors interact with PRS and affect changes in CRFs in each intervention group. Participants in both the lifestyle and metformin interventions had greater improvement in the majority of recognized CRFs compared with placebo (P < 0.001) irrespective of CAD genetic risk (P interaction > 0.05). We detected nominal significant interactions between PRS and dietary quality and physical activity on 1-year change in BMI, fasting glucose, triglycerides, and HDL cholesterol in individuals randomized to metformin or placebo, but none of them achieved the multiple-testing correction for significance. This study confirms that diabetes preventive interventions improve CRFs regardless of CAD genetic risk and delivers hypothesis-generating data on the varying benefit of increasing physical activity and improving diet on intermediate cardiovascular risk factors depending on individual CAD genetic risk profile.
- Published
- 2020
41. The Alberta Congenital Anomalies Surveillance System: a 40-year review with prevalence and trends for selected congenital anomalies, 1997–2019
- Author
-
R. Brian Lowry, Tanya Bedard, Xin Grevers, Susan Crawford, Steven C. Greenway, Mary E. Brindle, Harvey B. Sarnat, A. Robertson Harrop, Gerhard N. Kiefer, and Mary Thomas
- Subjects
Medicine (General) ,R5-920 - Abstract
IntroductionCurrent published long-term provincial or territorial congenital anomaly data are lacking for Canada. We report on prevalence (per 1000 total births) and trends in 1997–2019, in Alberta, Canada, for selected congenital anomalies. Associated risk factors are also discussed. MethodsWe used data from the Alberta Congenital Anomalies Surveillance System (ACASS) to calculate the prevalence and perform chi-square linear trend analyses. ResultsFrom 1997 to 2019, the overall prevalence of neural tube defects was stable, at 0.74 per 1000 total births. The same was true for spina bifida (0.38), orofacial clefts (1.99), more severe CHDs (transposition of the great arteries, 0.38; tetralogy of Fallot, 0.33; and hypoplastic left heart syndrome, 0.32); and gastroschisis (0.38). Anencephaly, cleft palate and anorectal malformation significantly decreased with a prevalence of 0.23, 0.75 and 0.54 per 1000 total births, respectively. Significantly increasing trends were reported for anotia/microtia (0.24), limb reduction anomalies (0.73), omphalocele (0.36) and Down syndrome (2.21) and for hypospadias and undescended testes (4.68 and 5.29, respectively, per 1000 male births). ConclusionCongenital anomalies are an important public health concern with significant social and societal costs. Surveillance data gathered by ACASS for over 40 years can be used for planning and policy decisions and the evaluation of prevention strategies. Contributing genetic and environmental factors are discussed as is the need for continued surveillance and research.
- Published
- 2023
- Full Text
- View/download PDF
42. Le système de surveillance des anomalies congénitales de l’Alberta : compte rendu des données sur 40 ans avec prévalence et tendances de certaines anomalies congénitales entre 1997 et 2019
- Author
-
R. Brian Lowry, Tanya Bedard, Xin Grevers, Susan Crawford, Steven C. Greenway, Mary E. Brindle, Harvey B. Sarnat, A. Robertson Harrop, Gerhard N. Kiefer, and Mary Thomas
- Subjects
Medicine (General) ,R5-920 - Abstract
IntroductionOn manque de données provinciales ou territoriales à long terme publiées et actuelles sur les anomalies congénitales Au Canada. Cette étude fait état de la prévalence (pour 1000 naissances totales) et des tendances pour diverses anomalies congénitales de 1997 à 2019 en Alberta (Canada). Les facteurs de risque associés sont également abordés. MethodsNous avons utilisé les données du Système de surveillance des anomalies congénitales de l’Alberta (ACASS) pour calculer la prévalence et effectuer des analyses de tendance linéaire par test du chi carré. ResultsEntre 1997 et 2019, la prévalence globale des anomalies du tube neural est demeurée stable, à 0,74 pour 1000 naissances totales. C’était également le cas pour le spina bifida (0,38), les fentes orofaciales (1,99), les cardiopathies congénitales graves (transposition des grandes artères, 0,38; tétralogie de Fallot, 0,33; hypoplasie du coeur gauche, 0,32) et le gastroschisis (0,38). L’anencéphalie, la fente palatine et les anomalies anorectales ont diminué significativement, avec une prévalence de respectivement 0,23, 0,75 et 0,54 pour 1000 naissances totales. Une tendance significativement à la hausse a été relevée pour l’anotie/microtie (0,24), les anomalies de raccourcissement des membres (0,73), l’omphalocèle (0,36) et le syndrome de Down (2,21), ainsi que pour l’hypospadias et la cryptorchidie (respectivement 4,68 et 5,29 pour 1 000 naissances masculines). ConclusionLes anomalies congénitales constituent un important problème de santé publique, qui est associé à des coûts sociaux et sociétaux substantiels. Les données de surveillance recueillies par l’ACASS sur plus de 40 ans peuvent servir à la planification et aux décisions en matière de politiques ainsi qu’à l’évaluation des stratégies de prévention. Les facteurs génétiques et environnementaux contributifs sont abordés, de même que la nécessité de poursuivre la surveillance et la recherche.
- Published
- 2023
- Full Text
- View/download PDF
43. Teaching Assistants' Facilitators and Barriers to Effective Practice Working with Children with ADHD: A Qualitative Study
- Author
-
Greenway, Charlotte W. and Rees Edwards, Alison
- Abstract
Attention-deficit/hyperactivity disorder (ADHD) rates have increased in recent years, resulting in the need for more classroom support. In Wales, support for many pupils with ADHD is provided by the 16,157 teaching assistants (TAs) employed by local authorities. This qualitative study interviewed 15 primary school TAs to answer three questions concerning their feelings about their job, and the facilitators and barriers to their work with children with ADHD. Using thematic analysis, the researchers identified 10 themes: positive feelings, negative effects, a need for change, support, improvement over time, one-to-one relationship, lack of support, negativity towards ADHD, classroom environment, and poor knowledge and experience with ADHD. This study illustrates the TAs' love for their job and the importance of positive relationships. It also highlights a lack of support for TAs and negativity towards ADHD. Implications of the study and recommendations for the future are discussed.
- Published
- 2021
- Full Text
- View/download PDF
44. Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research
- Author
-
Damba, Joseph Junior, Bodenstein, Katie, Lavin, Paola, Drury, Jessica, Sekhon, Harmehr, Renoux, Christel, Trinh, Emilie, Rej, Soham, and Greenway, Kyle T.
- Published
- 2022
- Full Text
- View/download PDF
45. One-step strategy for the synthesis of magnetic mesoporous carbon composite materials incorporating iron, cobalt and nickel nanoparticles
- Author
-
Athab, Zahraa H., Halbus, Ahmed F., and Greenway, Gillian M.
- Published
- 2022
- Full Text
- View/download PDF
46. Technical report: an online international weight control registry to inform precision approaches to healthy weight management
- Author
-
Roberts, Susan B., Das, Sai Krupa, Sayer, R. Drew, Caldwell, Ann E., Wyatt, Holly R., Mehta, Tapan S., Gorczyca, Anna M., Oslund, Jennifer L., Peters, John C., Friedman, James E., Chiu, Chia-Ying, Greenway, Frank L., Donnelly, Joseph E., Dao, Maria Carlota, Cuevas, Adolfo G., Affuso, Olivia, Wilkinson, Larrell L., Thomas, Diana, Al-Ozairi, Ebaa, Yannakoulia, Mary, Khazrai, Yeganeh M., Manalac, Raoul J., Bachiashvili, Vasil, and Hill, James O.
- Published
- 2022
- Full Text
- View/download PDF
47. Association of Acute Anti-inflammatory Treatment With Medium-term Outcomes for Coronary Artery Aneurysms in Kawasaki Disease
- Author
-
Kevin G. Friedman, MD, Brian W. McCrindle, MD, MPH, Kyle Runeckles, MSc, Nagib Dahdah, MD, Ashraf S. Harahsheh, MD, Michael Khoury, MD, Sean Lang, MD, Cedric Manlhiot, PhD, Adriana H. Tremoulet, MD, MAS, Geetha Raghuveer, MD, Elif Seda Selamet Tierney, MD, Pei-Ni Jone, MD, Jennifer S. Li, MD, MHS, Jacqueline R. Szmuszkovicz, MD, Kambiz Norozi, MD, PhD, Supriya S. Jain, MD, Angela T. Yetman, MD, Jane W. Newburger, MD, MPH, Carolyn A. Altman, MD, Brett R. Anderson, MD, MBA, MS, Mikayla Beckley, BS, Elizabeth Braunlin, MD, PhD, Jane C. Burns, MD, Michael R. Carr, MD, Nadine F. Choueiter, MD, Jessica H. Colyer, MD, MBA, Frederic Dallaire, MD, PhD, Sarah D. De Ferranti, MD, MPH, Laurent Desjardins, MD, Matthew D. Elias, MD, Anne Ferris, MBBS, Michael Gewitz, MD, Therese M. Giglia, MD, Steven C. Greenway, MD, Kevin C. Harris, MD, MHSc, Kevin D. Hill, MD, MSc, Michelle Hite, Thomas R. Kimball, MD, Shelby Kutty, MD, Lillian Lai, MD, MHA, Simon Lee, MD, Ming-Tai Lin, MD, PhD, Tisiana Low, MD, MSc, Andrew S. Mackie, MD, MSc, Wadi Mawad, MD, Mathew, MSc, Kimberly E. McHugh, MD, Tapas Mondal, MD, Kimberly Myers, MD, Michael A. Portman, MD, Claudia Renaud, MD, Rosie Scuccimarri, MD, S. Kristen Sexson Tejitel, MD, PhD, MPH, Karen M. Texter, MD, Deepika Thacker, MD, Sharon Wagner-Lees, RN-BC, BSN, Kenny Wong, MD, Mei-Hwan Wu, MD, PhD, and Varsha Zadokar, MBBS
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background: The impact of adjunctive anti-inflammatory treatment on outcomes for patients with Kawasaki disease (KD) and coronary artery aneurysms (CAAs) is unknown. Methods: Using data from the International KD Registry in patients with ≥ medium CAA we evaluate associations of treatment with outcomes and major adverse cardiac events (MACE). Results: Medium or large CAA was present in 527 (32%) patients. All were treated with intravenous immunoglobulin (IVIG), 70% were male, and the median age was 1.3 years (interquartile range: 0.4-4.0 years). The most common acute therapies included single IVIG alone in 243 (46%), multiple IVIG in 100 (19%), multiple IVIG + corticosteroids in 75 (14%), and multiple IVIG + infliximab + corticosteroids in 44 (8%) patients. Patients who received therapy beyond single IVIG had a larger CA z-score at baseline (P < 0.001) and a higher rate of bilateral CAA (P < 0.001). Compared with IVIG alone, early adjunctive treatments (within 3 days of initial IVIG) were not associated with time to CAA regression or MACE, whereas later adjunctive therapy was associated with MACE and longer time to CAA regression. Patients receiving IVIG plus steroids vs IVIG alone had a trend towards shorter time to CAA regression and lower risk of MACE (P = 0.07). A larger CAA z-score at baseline was the strongest predictor of an increase in the CAA z-score over follow-up, lower likelihood of CAA regression, and higher risk of MACE. Conclusions: Persistence of CAA and MACE are more strongly associated with baseline severity CAA than with acute adjuvant anti-inflammatory therapy. Patients who received late adjunctive therapy are at higher risk for worse outcomes. Résumé: Contexte: L’incidence d’un traitement anti-inflammatoire d’appoint chez les patients atteints de la maladie de Kawasaki (MK) compliquée d’anévrismes coronariens est inconnue. Méthodologie: À partir de données provenant du registre international de la maladie de Kawasaki portant sur les patients ayant subi des anévrismes coronariens modérés ou importants, nous avons évalué l’incidence des différents traitements sur les résultats cliniques et les événements cardiovasculaires indésirables majeurs (ECIM). Résultats: Des anévrismes coronariens modérés ou importants ont été relevés chez 527 patients (32 %). Tous les patients recevaient des immunoglobulines administrées par voie intraveineuse (IgIV); 70 % d’entre eux étaient de sexe masculin, et leur âge médian était de 1,3 an (écart interquartile : de 0,4 an à 4,0 ans). Les traitements d’urgence les plus fréquents comprenaient un seul traitement par IgIV chez 243 patients (46 %), plusieurs traitements par IgIV chez 100 patients (19 %), une association de plusieurs traitements IgIV et de corticostéroïdes chez 75 patients (14 %) et une association de plusieurs traitements IgIV, de corticostéroïdes et d’infliximab chez 44 patients (8 %). Les patients ayant reçu un traitement autre qu’un seul traitement IgIV présentaient des scores z initiaux plus élevés pour le diamètre des artères coronaires (P < 0,001) et un taux plus élevé d’anévrismes coronariens bilatéraux (P < 0,001). En comparaison d’un traitement par IgIV seulement, les traitements d’appoint précoces (administrés dans les trois jours suivant le début du traitement par IgIV) n’ont pas eu d’incidence sur la durée avant la régression des anévrismes coronariens ni sur la survenue d’ECIM, alors que les traitements d’appoint plus tardifs ont été associés à un risque plus élevé d’ECIM et à une régression plus tardive des anévrismes coronariens. Les patients ayant reçu une association d’IgIV et de corticostéroïdes avaient tendance à présenter une régression plus rapide des anévrismes coronariens et un plus faible risque d’ECIM que ceux recevant uniquement un traitement par IgIV (P = 0,07). Un score z initial plus élevé pour un anévrisme coronarien était le facteur prédictif le plus puissant d’une augmentation du score z pendant la période de suivi, d’une probabilité plus faible de régression de l’anévrisme et d’un risque plus élevé d’ECIM. Conclusions: La gravité initiale de l’anévrisme coronarien est plus fortement associée à la persistance de l’anévrisme et à la survenue d’ECIM que le recours à un traitement anti-inflammatoire d’urgence en appoint. Les patients recevant un traitement d’appoint tardif étaient par ailleurs plus susceptibles de présenter des résultats défavorables.
- Published
- 2022
- Full Text
- View/download PDF
48. Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings
- Author
-
Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, and Kyle T. Greenway
- Subjects
psychedelics ,ketamine ,set and setting ,hallucinations ,imprinting ,extra-pharmacological model ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
BackgroundPsychedelic drug experiences are shaped by current-moment contextual factors, commonly categorized as internal (set) and external (setting). Potential influences of past environments, however, have received little attention.AimsTo investigate how previous environmental stimuli shaped the experiences of patients receiving ketamine for treatment-resistant depression (TRD), and develop the concept of “imprinting” to account for such time-lagged effects across diverse hallucinogenic drugs.MethodsRecordings of treatment sessions and phenomenological interviews from 26 participants of a clinical trial investigating serial intravenous ketamine infusions for TRD, conducted from January 2021 to August 2022, were retrospectively reviewed. A broad literature search was undertaken to identify potentially underrecognized examples of imprinting with both serotonergic and atypical psychedelics, as well as analogous cognitive processes and neural mechanisms.ResultsIn naturalistic single-subject experiments of a 28-year-old female and a 34-year-old male, subjective ketamine experiences were significantly altered by varying exposures to particular forms of digital media in the days preceding treatments. Higher levels of media exposure reduced the mystical/emotional qualities of subsequent psychedelic ketamine experiences, overpowering standard intention-setting practices and altering therapeutic outcomes. Qualitative data from 24 additional patients yielded eight further spontaneous reports of past environmental exposures manifesting as visual hallucinations during ketamine experiences. We identified similar examples of imprinting with diverse psychoactive drugs in past publications, including in the first-ever report of ketamine in human subjects, as well as analogous processes known to underly dreaming.Conclusions/interpretationPast environmental exposures can significantly influence the phenomenology and therapeutic outcomes of psychedelic experiences, yet are underrecognized and understudied. To facilitate future research, we propose expanding the contextual model of psychedelic drug actions to incorporate imprinting, a novel concept that may aid clinicians, patients, and researchers to better understand psychedelic drug effects.Clinical trial registrationClinicalTrials.gov, identifier NCT04701866.
- Published
- 2023
- Full Text
- View/download PDF
49. Boost your brain: a simple 100% normobaric oxygen treatment improves human motor learning processes
- Author
-
Zheng Wang, Guillaume Spielmann, Neil Johannsen, Frank Greenway, Brian A. Irving, and Marc Dalecki
- Subjects
oxygen treatment (OT) ,sensorimotor system ,visuomotor adaptation ,motor learning ,normobaric ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
IntroductionHuman motor learning processes are a fundamental part of our daily lives and can be adversely affected by neurologic conditions. Motor learning largely depends on successfully integrating cognitive and motor-related sensory information, and a simple, easily accessible treatment that could enhance such processes would be exciting and clinically impactful. Normobaric 100% oxygen treatment (NbOxTr) is often used as a first-line intervention to improve survival rates of brain cells in neurological trauma, and recent work indicates that improvements in elements crucial for cognitive-motor-related functions can occur during NbOxTr. However, whether NbOxTr can enhance the motor learning processes of healthy human brains is unknown. Here, we investigated whether a brief NbOxTr administered via nasal cannula improves motor learning processes during a visuomotor adaptation task where participants adapt to a visual distortion between visual feedback and hand movements.Methods40 healthy young adults (M = 21 years) were randomly assigned to a NbOxTr (N = 20; 100% oxygen) or air (N = 20; regular air) group and went through four typical visuomotor adaptation phases (Baseline, Adaptation, After-Effect, Refresher). Gas treatment (flow rate 5 L/min) was only administered during the Adaptation phase of the visuomotor experiment, in both groups.ResultsThe NbOxTr provided during the Adaptation phase led to significantly faster and about 30% improved learning (p < 0.05). Notably, these motor learning improvements consolidated into the subsequent experiment phases, i.e., after the gas treatment was terminated (p < 0.05).DiscussionWe conclude that this simple and brief NbOxTr dramatically improved fundamental human motor learning processes and may provide promising potential for neurorehabilitation and skill-learning approaches. Further studies should investigate whether similar improvements exist in elderly and neurologically impaired individuals, other motor learning tasks, and also long-lasting effects.
- Published
- 2023
- Full Text
- View/download PDF
50. Editorial: Stress-induced weight changes
- Author
-
Hassan M. Heshmati, Livio Luzi, Frank L. Greenway, and Candida J. Rebello
- Subjects
stress ,stressor ,weight change ,obesity ,weight loss ,prevention ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.